Skip to Main Content

Paper Details

Once-daily tasimelteon (VEC-162) for jet lag following transmeridian travel: A multicenter, randomized, double-blind, placebo-controlled trial.
Front Neurol
1
2022
Author NameAffiliation
Sandra P SmieszekVanda Pharmaceuticals Inc.
  • 1 - 1

Datasets

Release 1.2